CSF1R and myeloid sarcoma: Elevated levels of the potential PET targets P2 × 7R, COX-2, CB2R and CSF-1R have been demonstrated immunohistochemically in lesions in human MS and EAE (Yiangou et al., 2006; Beaino et al., 2017; Hagan et al., 2020).